ASTRAZENECA PLC (AZN)
Clinical trial NCT05557838 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. start date: 2023-02-22 → 2023-02-15 3. completion date: 2025-03-31 → 2026-09-30 4. primary completion date: 2025-03-31 → 2026-09-30 5. enrollment: 210 → 214 participants 6. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (61%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (25%) **Content type:** Clinical